Risk Factors for Sleep Problems Prior to Radiochemotherapy for Malignant Gliomas

Svenja Kopelke; Troels W Kjaer; Soeren Tvilsted; Steven E Schild; Tobias Bartscht; Dirk Rades

doi:10.21873/invivo.12705

Risk Factors for Sleep Problems Prior to Radiochemotherapy for Malignant Gliomas

Svenja Kopelke, Troels W Kjaer, Soeren Tvilsted, Steven E Schild, Tobias Bartscht, Dirk Rades^*

^*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskrift › Artikel › Forskning › peer review

Abstract

BACKGROUND/AIM: Many patients with malignant gliomas are scheduled for radiochemotherapy, which may cause emotional distress associated with sleep problems. This study aimed to determine the prevalence of such sleep problems in these patients and identify risk factors.

PATIENTS AND METHODS: Fifty-seven patients scheduled for radiochemotherapy for grade II-IV gliomas were retrospectively investigated for pre-treatment sleep problems. Fifteen characteristics were evaluated including temporal relation to COVID-19 pandemic, age, gender, performance status, comorbidity, (family) history of malignancies, distress score, emotional problems, physical problems, practical problems, involved sites, glioma grade, upfront surgery, and corticosteroids.

RESULTS: Nineteen patients stated pre-treatment sleep problems (prevalence=66.7%). Significant associations with sleep problems were found for female gender (p=0.023), presence of emotional problems (p=0.006), and ≥4 physical problems (p<0.001). A trend was found for distress scores ≥5 (p=0.077).

CONCLUSION: The prevalence of sleep problems was high. Risk factors were determined that can be used to identify patients who likely benefit from psychological support.

Originalsprog	Engelsk
Sider (fra-til)	325-329
Antal sider	5
Tidsskrift	In Vivo
Vol/bind	36
Udgave nummer	1
DOI	https://doi.org/10.21873/invivo.12705
Status	Udgivet - 2 jan. 2022

Bibliografisk note

Adgang til dokumentet

10.21873/invivo.12705

Citationsformater

@article{da5a1ab04eb44509940d318d025ea97d,

title = "Risk Factors for Sleep Problems Prior to Radiochemotherapy for Malignant Gliomas",

abstract = "BACKGROUND/AIM: Many patients with malignant gliomas are scheduled for radiochemotherapy, which may cause emotional distress associated with sleep problems. This study aimed to determine the prevalence of such sleep problems in these patients and identify risk factors.PATIENTS AND METHODS: Fifty-seven patients scheduled for radiochemotherapy for grade II-IV gliomas were retrospectively investigated for pre-treatment sleep problems. Fifteen characteristics were evaluated including temporal relation to COVID-19 pandemic, age, gender, performance status, comorbidity, (family) history of malignancies, distress score, emotional problems, physical problems, practical problems, involved sites, glioma grade, upfront surgery, and corticosteroids.RESULTS: Nineteen patients stated pre-treatment sleep problems (prevalence=66.7%). Significant associations with sleep problems were found for female gender (p=0.023), presence of emotional problems (p=0.006), and ≥4 physical problems (p<0.001). A trend was found for distress scores ≥5 (p=0.077).CONCLUSION: The prevalence of sleep problems was high. Risk factors were determined that can be used to identify patients who likely benefit from psychological support.",

keywords = "COVID-19, Chemoradiotherapy, Female, Glioma/complications, Humans, Pandemics, Retrospective Studies, Risk Factors, SARS-CoV-2, Sleep Wake Disorders/epidemiology",

author = "Svenja Kopelke and Kjaer, {Troels W} and Soeren Tvilsted and Schild, {Steven E} and Tobias Bartscht and Dirk Rades",

year = "2022",

month = jan,

day = "2",

doi = "10.21873/invivo.12705",

language = "English",

volume = "36",

pages = "325--329",

journal = "In Vivo",

issn = "0258-851X",

publisher = "International Institute of Anticancer Research",

number = "1",

}

TY - JOUR

T1 - Risk Factors for Sleep Problems Prior to Radiochemotherapy for Malignant Gliomas

AU - Kopelke, Svenja

AU - Kjaer, Troels W

AU - Tvilsted, Soeren

AU - Schild, Steven E

AU - Bartscht, Tobias

AU - Rades, Dirk

PY - 2022/1/2

Y1 - 2022/1/2

N2 - BACKGROUND/AIM: Many patients with malignant gliomas are scheduled for radiochemotherapy, which may cause emotional distress associated with sleep problems. This study aimed to determine the prevalence of such sleep problems in these patients and identify risk factors.PATIENTS AND METHODS: Fifty-seven patients scheduled for radiochemotherapy for grade II-IV gliomas were retrospectively investigated for pre-treatment sleep problems. Fifteen characteristics were evaluated including temporal relation to COVID-19 pandemic, age, gender, performance status, comorbidity, (family) history of malignancies, distress score, emotional problems, physical problems, practical problems, involved sites, glioma grade, upfront surgery, and corticosteroids.RESULTS: Nineteen patients stated pre-treatment sleep problems (prevalence=66.7%). Significant associations with sleep problems were found for female gender (p=0.023), presence of emotional problems (p=0.006), and ≥4 physical problems (p<0.001). A trend was found for distress scores ≥5 (p=0.077).CONCLUSION: The prevalence of sleep problems was high. Risk factors were determined that can be used to identify patients who likely benefit from psychological support.

AB - BACKGROUND/AIM: Many patients with malignant gliomas are scheduled for radiochemotherapy, which may cause emotional distress associated with sleep problems. This study aimed to determine the prevalence of such sleep problems in these patients and identify risk factors.PATIENTS AND METHODS: Fifty-seven patients scheduled for radiochemotherapy for grade II-IV gliomas were retrospectively investigated for pre-treatment sleep problems. Fifteen characteristics were evaluated including temporal relation to COVID-19 pandemic, age, gender, performance status, comorbidity, (family) history of malignancies, distress score, emotional problems, physical problems, practical problems, involved sites, glioma grade, upfront surgery, and corticosteroids.RESULTS: Nineteen patients stated pre-treatment sleep problems (prevalence=66.7%). Significant associations with sleep problems were found for female gender (p=0.023), presence of emotional problems (p=0.006), and ≥4 physical problems (p<0.001). A trend was found for distress scores ≥5 (p=0.077).CONCLUSION: The prevalence of sleep problems was high. Risk factors were determined that can be used to identify patients who likely benefit from psychological support.

KW - COVID-19

KW - Chemoradiotherapy

KW - Female

KW - Glioma/complications

KW - Humans

KW - Pandemics

KW - Retrospective Studies

KW - Risk Factors

KW - SARS-CoV-2

KW - Sleep Wake Disorders/epidemiology

U2 - 10.21873/invivo.12705

DO - 10.21873/invivo.12705

M3 - Article

C2 - 34972729

SN - 0258-851X

VL - 36

SP - 325

EP - 329

JO - In Vivo

JF - In Vivo

IS - 1

ER -

Risk Factors for Sleep Problems Prior to Radiochemotherapy for Malignant Gliomas

Abstract

Bibliografisk note

Adgang til dokumentet

Fingeraftryk

Citationsformater